Complicações bucais em crianças e adolescentes hospitalizadas durante o tratamento antineoplasico
DOI:
https://doi.org/10.7322/jhgd.137142Palavras-chave:
quimioterapia, radioterapia, saúde bucal, mucosite, xerostomiaResumo
Introdução: Durante o tratamento antineoplásico, células normais também são afetadas, incluindo assim, as células da mucosa oral, o que potencialmente causa complicações orais.
Objetivo: O presente trabalho teve por objetivo avaliar a prevalência das principais complicações bucais e índice de higiene oral em crianças e adolescentes submetidas à quimioterapia e/ou radioterapia.
Método: O delineamento é do tipo observacional de prevalência realizado em um Hospital do Sul do Brasil. Foram coletados dados de 21 pacientes de 5 a 12 anos de idade em tratamento, a partir de um questionário auto aplicativo para os responsáveis pelos pacientes e um exame clínico intraoral. Os indicadores utilizados foram o índice CPOD (dentes cariados, perdidos e obturados) para cárie dentária, o índice IHOS (higiene oral simplificada) para Higiene Oral e a presença de mucosite, xerostomia e candidíase.
Resultados: A maior parte da amostra era do sexo masculino (57,1%) média de 8 anos de idade (dp 2,92), diagnosticados com leucemia (47,6%). Todos os participantes receberam quimioterapia como tratamento de escolha e 38,1% receberam radioterapia como parte do tratamento. Os resultados evidenciariam presença de mucosite em 61,9% e xerostomia em 28,6% dos pacientes. Nenhum paciente apresentou candidíase durante o exame clínico. Quanto a cárie dentária, 66,7% tem um CPOD de 4 e 16, considerado alto e 38,1% dos pacientes apresentaram presença de placa bacteriana e cálculo dentário.
Conclusão: As principais complicações bucais evidenciadas durante o tratamento antineoplásico foram mucosite e xerostomia. Foi observado também um alto índice de cárie dentária, consequência de uma inadequada higiene oral.
Referências
Figueiredo PBA, Nogueira AJS. Prevalence of Neoplasia, Caries and Gingivitis in Pediatric Cancer Patients in the City of Belém, PA, Brazil. Pesq Bras Odontoped Clin Integr. 2013; 1 3 (2):141-6.
National Cancer Institute. NCI. Available from: http://www.inca.gov.br/tumores_infantis/pdf/9_resultados_comentarios_incidencia_por_tipo_de_cancer.pdf. Accessed in 2016 (25 jun).
Goursand D, Borges CM, Alves KM, Nascimento AM, Winter RR, Martins LHPM, Zarzar PMPA, Paiva SM. Sequelas bucais em crianças submetidas a terapia antineoplásica: causas e definição do papel do Cirurgião-dentista. Arquivos em Odontologia. 2006; 42(3): 161-265.
Lopes IA, Nogueira DA, Lopes IA. Oral Manifestations of Chemotherapy in Children from a Cancer Treatment Center. Pesquisa Brasileira em Odontopediatria e Clínica Integrada. 2012; 12 (1):113-19.
Araujo SNM, Luz MHBA, Silva GRF, Andrade EMLR, Nunes LCC, Moura RO. O paciente oncológico com mucosite oral: desafios para o cuidado de enfermagem. Rev Lat Am Enfermagem. 2015; 23(2):267-74.
Grimald N, Sarmento V, Provedel L, Almeida D, Cunha S. Dental care in prevention and treatment of osteoradionecrosis: literature review. Revista Brasileira de Cancerologia. 2005; 51(4): 319-324.
Silva MAGS, Mendonça EF, Rodrigues KFM, Bariani C, Silva GBL. The utilization of the low energy laser and chlorhexidine 0,12% in the management of oral mucositis due to chemotherapy in children with leukemia. Robrac. 2006; 15(6): 24-31.
Kroetz FM, Czlusniak GD. Oral alterations in juvenile patients submitted to radiotherapy and chemotherapy. Publication UEPG Ciências Biológicas e da Saúde. 2003; 9(2): 41-48.
Barbosa AM, Ribeiro DM, Caldo-Teixeira AS. Knowledge and practices of oral health on hospitalized children with cancer. Ciência & Saúde Coletiva. 2010; 15 (1):1113-22.
Morais EF, Lira JA, Macedo RA, Santos KS, Elias CT, Morais ML. Oral manifestations resulting from chemotherapy in children with acute lymphoblastic leukemia. Brazilian journal of otorhinolaryngology. 2014; 80(1): 78-85.
Albuquerque RA, Morais VLL, Sobral APV. Odontologic protocol of attendance the pediatric oncology patients: review of literature. Revista de Odontologia da UNESP. 2007; 36(3):275-280.
Mouchrek Junior, JCEM, Trovão MMA. Mouchrek Junior, JCEM, Trovão MMA. Assessment of the plaque and gingival indices of children with neoplasy submitted to antineoplastic treatment. Revista Brasileira de Odontologia. 2010; 67(1): 101-5.
Zevallos JP, Mallen MJ, Lam CY, Karam-Hage M, Blalock J, Wetter DW, Garden AS, Sturgis EM, Cinciripini PM. Complications of radiotherapy in laryngopharyngeal cancer: effects of a prospective smoking cessation program. 2009; 115 (19): 4636-44.
Grabois MF, Oliveira EXG, Carvalho MS. Access to pediatric cancer care in Brazil: mapping origin-destination flows. Revista de Saúde Pública. 2013;47(2):368-378.
Greene JC, Vermillion JR. The simplified oral hygiene index. The Journal of the American Dental Association. 1964; 68:7-13.
Klein H, Palmer CE. Dental caries in American Indian children. Publ. Hlth Bull. 1937; 239:1-54.
Santos VI, Anbinder AL, Cavalcante ASR. Pediatric patients with leukemia: dental care. Cienc Odontol Bras 2003; 6 (2): 49-57.
Gordón-Núñez MA, Silva Júnior FL, Galvão HC, Souza LB, Pinto LP. Neutropenia and Oral Mucositis: risk factors for Candidiasis in Children with Cancer. Revista Odontológica do Brasil Central. 2010; 18(48): 51-6.
Kung AYH, Zhang S, Zheng LW, Wong GHM, Chu CH. Oral Health Status of Chinese Pediatric and Adolescent Oncology Patients with Chemotherapy in Hong Kong: a Pilot Study. The Open Dentistry Journal. 2015; 9(1): 21-30.
Bueno AC, Magalhaes CS, Moreira AN. Association Between Risk Factors And Oral Complications In Patients With Head And Neck Cancer Treated With Radiotherapy Combined Or Not With Chemotherapy. Pesq Bras Odontoped Clin Integr. 2012; 12(2):187-93.
Kreuger MRO, Savoldi LW, Hoffman S, Diegoli NM. Oral Manifestation in Patients during Chemotherapy treatment at UNACON, Itajaí/SC. Faculdade de Odontologia de Lins/Unimep. 2008; 21(1):39-47.
Sera EAR, Oliveira RV, Mariotto AH, Aquino DR, Scherma AP. Assessment of dental care before and during radiotherapy treatment. Brazilian Society of Periodontology. 2013; 23 (3): 30-8.
Hespanhol LF, Tinoco EMB, Teixeira HGC, Falabella MEV, Assis NMSP. Buccal manifestations in patients submitted to chemotherapy. Ciência & Saúde Coletiva. 2010; 15 (1): 1085-94.
Azher A, Shiggaon N. Oral health status of children with acute lymphoblastic leukemia undergoing chemotherapy. Indian Journal of Dental Research. 2003; 24 (4): 12-5.
Downloads
Publicado
Edição
Seção
Licença
CODE OF CONDUCT FOR JOURNAL PUBLISHERS
Publishers who are Committee on Publication Ethics members and who support COPE membership for journal editors should:
- Follow this code, and encourage the editors they work with to follow the COPE Code of Conduct for Journal Edi- tors (http://publicationethics.org/files/u2/New_Code.pdf)
- Ensure the editors and journals they work with are aware of what their membership of COPE provides and en- tails
- Provide reasonable practical support to editors so that they can follow the COPE Code of Conduct for Journal Editors (http://publicationethics.org/files/u2/New_Code.pdf_)
Publishers should:
- Define the relationship between publisher, editor and other parties in a contract
- Respect privacy (for example, for research participants, for authors, for peer reviewers)
- Protect intellectual property and copyright
- Foster editorial independence
Publishers should work with journal editors to:
- Set journal policies appropriately and aim to meet those policies, particularly with respect to:
– Editorial independence
– Research ethics, including confidentiality, consent, and the special requirements for human and animal research
– Authorship
– Transparency and integrity (for example, conflicts of interest, research funding, reporting standards
– Peer review and the role of the editorial team beyond that of the journal editor
– Appeals and complaints
- Communicate journal policies (for example, to authors, readers, peer reviewers)
- Review journal policies periodically, particularly with respect to new recommendations from the COPE
- Code of Conduct for Editors and the COPE Best Practice Guidelines
- Maintain the integrity of the academic record
- Assist the parties (for example, institutions, grant funders, governing bodies) responsible for the investigation of suspected research and publication misconduct and, where possible, facilitate in the resolution of these cases
- Publish corrections, clarifications, and retractions
- Publish content on a timely basis
